166 related articles for article (PubMed ID: 34980830)
21. A rare case of primary anaplastic large cell lymphoma of the central nervous system.
Kuntegowdenahalli LC; Jacob LA; Komaranchath AS; Amirtham U
J Cancer Res Ther; 2015; 11(4):943-5. PubMed ID: 26881551
[TBL] [Abstract][Full Text] [Related]
22. Genomic profiling of peripheral T-cell lymphoma, unspecified, and anaplastic large T-cell lymphoma delineates novel recurrent chromosomal alterations.
Zettl A; Rüdiger T; Konrad MA; Chott A; Simonitsch-Klupp I; Sonnen R; Müller-Hermelink HK; Ott G
Am J Pathol; 2004 May; 164(5):1837-48. PubMed ID: 15111330
[TBL] [Abstract][Full Text] [Related]
23. High intratumoural galectin-1 expression predicts adverse outcome in ALK
Holst JM; Ludvigsen M; Hamilton-Dutoit SJ; Bendix K; Plesner TL; Nørgaard P; Møller MB; Steiniche T; Rabinovich GA; d'Amore F; Pedersen MB
Hematol Oncol; 2020 Feb; 38(1):59-66. PubMed ID: 31834627
[TBL] [Abstract][Full Text] [Related]
24. Analysis of Peripheral T-cell Lymphoma Diagnostic Workup in the United States.
Hsi ED; Horwitz SM; Carson KR; Pinter-Brown LC; Rosen ST; Pro B; Federico M; Gisselbrecht C; Schwartz M; Bellm LA; Acosta M; Collie AM; Gruver AM; Grzywacz BJ; Turakhia S; Shustov AR; Advani RH; Feldman T; Lechowicz MJ; Smith SM; Lansigan F; Tulpule A; Craig MD; Greer JP; Kahl BS; Leach JW; Morganstein N; Casulo C; Park SI; Foss FM
Clin Lymphoma Myeloma Leuk; 2017 Apr; 17(4):193-200. PubMed ID: 28209473
[TBL] [Abstract][Full Text] [Related]
25. Epstein-Barr virus-positive nodal T/NK-cell lymphoma: an analysis of 15 cases with distinct clinicopathological features.
Jeon YK; Kim JH; Sung JY; Han JH; Ko YH;
Hum Pathol; 2015 Jul; 46(7):981-90. PubMed ID: 25907865
[TBL] [Abstract][Full Text] [Related]
26. Primary cutaneous peripheral T-cell lymphomas with a T-follicular helper phenotype: an integrative clinical, pathological and molecular case series study.
Wang L; Rocas D; Dalle S; Sako N; Pelletier L; Martin N; Dupuy A; Tazi N; Balme B; Vergier B; Beylot-Barry M; Carlotti A; Bagot M; Battistella M; Chaby G; Ingen-Housz-Oro S; Gaulard P; Ortonne N
Br J Dermatol; 2022 Dec; 187(6):970-980. PubMed ID: 35895386
[TBL] [Abstract][Full Text] [Related]
27. Molecular features of non-anaplastic peripheral T-cell lymphoma in children and adolescents.
Au-Yeung RKH; Richter J; Iaccarino I; Abramov D; Bacon CM; Balagué O; d'Amore ESG; Simonitsch-Klupp I; Hebeda K; Nakazawa A; Oschlies I; Kontny U; Woessmann W; Burkhardt B; Klapper W
Pediatr Blood Cancer; 2021 Nov; 68(11):e29285. PubMed ID: 34390161
[TBL] [Abstract][Full Text] [Related]
28. T-cell receptor (TCR) phenotype of nodal Epstein-Barr virus (EBV)-positive cytotoxic T-cell lymphoma (CTL): a clinicopathologic study of 39 cases.
Kato S; Asano N; Miyata-Takata T; Takata K; Elsayed AA; Satou A; Takahashi E; Kinoshita T; Nakamura S
Am J Surg Pathol; 2015 Apr; 39(4):462-71. PubMed ID: 25634749
[TBL] [Abstract][Full Text] [Related]
29. JAK2 Rearrangements Are a Recurrent Alteration in CD30+ Systemic T-Cell Lymphomas With Anaplastic Morphology.
Fitzpatrick MJ; Massoth LR; Marcus C; Vergilio JA; Severson E; Duncan D; Ramkissoon SH; Hasserjian RP; Kim AS; Sohani AR; Williams EA; Nardi V
Am J Surg Pathol; 2021 Jul; 45(7):895-904. PubMed ID: 34105517
[TBL] [Abstract][Full Text] [Related]
30. The frequency of immunoglobulin heavy chain gene and T-cell receptor gamma-chain gene rearrangements and Epstein-Barr virus in ALK+ and ALK- anaplastic large cell lymphoma and other peripheral T-cell lymphomas.
Tan BT; Seo K; Warnke RA; Arber DA
J Mol Diagn; 2008 Nov; 10(6):502-12. PubMed ID: 18832464
[TBL] [Abstract][Full Text] [Related]
31. The risk of central nervous system relapses in patients with peripheral T-cell lymphoma.
Chihara D; Fanale MA; Miranda RN; Noorani M; Westin JR; Nastoupil LJ; Hagemeister FB; Fayad LE; Romaguera JE; Samaniego F; Turturro F; Lee HJ; Neelapu SS; Rodriguez MA; Wang M; Fowler NH; Davis RE; Medeiros LJ; Oki Y
PLoS One; 2018; 13(3):e0191461. PubMed ID: 29538376
[TBL] [Abstract][Full Text] [Related]
32. The clinical significance of activated p-AKT expression in peripheral T-cell lymphoma.
Hong JY; Hong ME; Choi MK; Chang W; Do IG; Jo JS; Jung SH; Park S; Kim SJ; Ko YH; Kim WS
Anticancer Res; 2015 Apr; 35(4):2465-74. PubMed ID: 25862915
[TBL] [Abstract][Full Text] [Related]
33. Classification and diagnostic evaluation of nodal T- and NK-cell lymphomas.
Feldman AL; Laurent C; Narbaitz M; Nakamura S; Chan WC; de Leval L; Gaulard P
Virchows Arch; 2023 Jan; 482(1):265-279. PubMed ID: 36210383
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr virus-positive nodal peripheral T cell lymphomas: clinicopathologic and gene expression profiling study.
Ha SY; Sung J; Ju H; Karube K; Kim SJ; Kim WS; Seto M; Ko YH
Pathol Res Pract; 2013 Jul; 209(7):448-54. PubMed ID: 23735590
[TBL] [Abstract][Full Text] [Related]
35. Nodal cytotoxic lymphoma spectrum: a clinicopathologic study of 66 patients.
Kagami Y; Suzuki R; Taji H; Yatabe Y; Takeuchi T; Maeda S; Kondo E; Kojima M; Motoori T; Mizoguchi Y; Okamoto M; Ohnishi K; Yamabe H; Seto M; Ogura M; Koshikawa T; Takahashi T; Kurita S; Morishima Y; Suchi T; Nakamura S
Am J Surg Pathol; 1999 Oct; 23(10):1184-200. PubMed ID: 10524519
[TBL] [Abstract][Full Text] [Related]
36. Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma.
Iqbal J; Wright G; Wang C; Rosenwald A; Gascoyne RD; Weisenburger DD; Greiner TC; Smith L; Guo S; Wilcox RA; Teh BT; Lim ST; Tan SY; Rimsza LM; Jaffe ES; Campo E; Martinez A; Delabie J; Braziel RM; Cook JR; Tubbs RR; Ott G; Geissinger E; Gaulard P; Piccaluga PP; Pileri SA; Au WY; Nakamura S; Seto M; Berger F; de Leval L; Connors JM; Armitage J; Vose J; Chan WC; Staudt LM;
Blood; 2014 May; 123(19):2915-23. PubMed ID: 24632715
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathologic Features of Peripheral T-Cell Lymphoma in Sub-Saharan Africa.
Fitzpatrick MJ; Sayed S; Moloo Z; Kayembe MKA; Roberts DJ; Pham TA; Xi L; Raffeld M; Louissaint A; Sohani AR
Am J Clin Pathol; 2021 Jun; 156(1):42-55. PubMed ID: 33527979
[TBL] [Abstract][Full Text] [Related]
38. Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic γδ T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro.
Iqbal J; Weisenburger DD; Chowdhury A; Tsai MY; Srivastava G; Greiner TC; Kucuk C; Deffenbacher K; Vose J; Smith L; Au WY; Nakamura S; Seto M; Delabie J; Berger F; Loong F; Ko YH; Sng I; Liu X; Loughran TP; Armitage J; Chan WC;
Leukemia; 2011 Feb; 25(2):348-58. PubMed ID: 21052088
[TBL] [Abstract][Full Text] [Related]
39. Extranodal natural killer/T-cell lymphoma coexisting with peripheral T-cell lymphoma, not otherwise specified.
Hayashino K; Yoshida C; Ayata Y; Yukawa R; Komura A; Nakamura M; Meguri Y; Yamamoto K; Oda W; Imajo K
J Clin Exp Hematop; 2024; 64(1):52-58. PubMed ID: 38538319
[TBL] [Abstract][Full Text] [Related]
40. Expression of activating natural killer-cell receptors is a hallmark of the innate-like T-cell neoplasm in peripheral T-cell lymphomas.
Uemura Y; Isobe Y; Uchida A; Asano J; Nishio Y; Sakai H; Hoshikawa M; Takagi M; Nakamura N; Miura I
Cancer Sci; 2018 Apr; 109(4):1254-1262. PubMed ID: 29363227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
